NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Synthesis Capital

Synthesis Capital

London, Englandsynthesis.capital

Overview

Synthesis Capital is a global food technology and alternative protein investor. The firm invests in companies that specialize in the alternative protein technology sector across the United Kingdom and the United States, integrating food technology and modern biotechnology to create innovative solutions that address key challenges in food production, sustainability, and nutrition .

Year Founded

2014

AUM

$300M

Portfolio Companies

15

Investments

Synthesis Capital investments
CompanyDateStageLead
Culture BiosciencesDec 2025Series CCo-investor
Pow.BioApr 2025Series A ExtensionLead
SavorFeb 2024Series ALead
SavorFeb 2024Series ACo-investor
TriplebarOct 2023Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2014
AUM$300M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.